Effect of comorbidities on outcomes and ivabradine effects in patients with chronic systolic heart failure in the SHIFT trial

被引:0
|
作者
Bohm, Servier M. [1 ]
Borer, J. S. [2 ]
Ford, I. [3 ]
Lainscak, M. [4 ]
Komajda, M. [5 ]
Robertson, M. [3 ]
Tavazzi, L. [6 ]
Swedberg, K. [7 ]
机构
[1] Univ Saarlandes Kliniken, Innere Med Klin 3, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
[4] Gen Hosp Celje, Dept Cardiol, Celje, Slovenia
[5] Univ Paris 06, La Pitie Salpetriere Hosp, Dept Cardiol, Paris, France
[6] Ettore Sansavini Hlth Sci Fdn, Maria Cecilia Hosp GVM Care & Res, Cotignola, Italy
[7] Univ Gothenbur, Sahlgrenska Acad, Dept Emergency & Cardiovasc Med, Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1283
引用
收藏
页码:266 / 266
页数:1
相关论文
共 50 条
  • [31] The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure
    Ozturk, Serkan
    Ozturk, Selcuk
    Erdem, Fatma Hizal
    Erdem, Alim
    Ayhan, Selim
    Donmez, Ibrahim
    Yazici, Mehmet
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2016, 46 (03) : 253 - 258
  • [32] The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure
    Serkan Ozturk
    Selçuk Öztürk
    Fatma Hizal Erdem
    Alim Erdem
    Selim Ayhan
    İbrahim Dönmez
    Mehmet Yazıcı
    Journal of Interventional Cardiac Electrophysiology, 2016, 46 : 253 - 258
  • [33] Estimation of Decrements of Utility Associated With Hospitalizations in a Population With Heart Failure From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanimira
    Kansal, Anuraag R.
    Zheng, Ying
    Patel, Harshali K.
    Kielhorn, Adrian
    Bohm, Michael
    Tavazzi, Luigi
    Ford, Ian
    CIRCULATION, 2016, 134
  • [34] Efficacy of ivabradine therapy on right heart parameters and prognosis in patients with severe systolic chronic heart failure
    Tumasyan, L. R.
    Adamyan, K. G.
    Chilingaryan, A. L.
    EUROPEAN HEART JOURNAL, 2012, 33 : 808 - 808
  • [35] Pharmacology of Ivabradine and the Effect on Chronic Heart Failure
    Zhou, Yue
    Wang, Jian
    Meng, Zhuo
    Zhou, Shuang
    Peng, Jiayu
    Chen, Sun
    Wang, Qingjie
    Sun, Kun
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (21) : 1878 - 1901
  • [36] Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT
    Boehm, Michael
    Lloyd, Suzanne M.
    Ford, Ian
    Borer, Jeffrey S.
    Ewen, Sebastian
    Laufs, Ulrich
    Mahfoud, Felix
    Lopez-Sendon, Jose
    Ponikowski, Piotr
    Tavazzi, Luigi
    Swedberg, Karl
    Komajda, Michel
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (06) : 672 - 683
  • [37] Ivabradine - well tolerated in elderly patients with systolic heart failure
    Zivlas, Christos
    Foley, Paul W. X.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : 330 - 331
  • [38] The Effects of Ivabradine on Left Ventricular Synchronization and Tei Index in Patients with Systolic Heart Failure
    Erdem, Fatma Hizal
    Ozturk, Serkan
    Ozturk, Selcuk
    Erdem, Alim
    Ayhan, Selim
    Ozturk, Mustafa
    Donmez, Ibrahim
    Baltaci, Davut
    Yazici, Mehmet
    ACTA CARDIOLOGICA SINICA, 2017, 33 (01) : 58 - 65
  • [39] Effect of Ivabradine on Readmission: A Post-Hoc Bayesian Analysis of 30-day Readmission Rates in the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanmira
    Kansal, Anuraag R.
    Ishak, K. Jack
    Kielhorn, Adrian
    Patel, Harshali
    Borer, Jeffery S.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S107 - S107
  • [40] Clinical profiles and outcomes of patients with chronic heart failure and diabetes: efficacy and safety of ivabradine. a shift study analysis
    Komajda, M.
    Tavazzi, L.
    Swedberg, K.
    Bohm, M.
    Borer, J. S.
    Robertson, M.
    Ford, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 42 - 42